What You'll Experience at LTEN 2026
We’re excited to see our clients, partners, and friends at LTEN! In advance of the conference, we...
.jpg)
What You'll Experience at LTEN 2026
AI in Drug Development Is Changing the Field Conversation: Are MSLs and Sales Teams Ready?
From AI Hype to Field Reality Much of the current discussion around AI and field readiness has...
Planning for the Unexpected: Training for Launch When Timelines Change
Product launches in life sciences are built on months and even years of careful planning, with...
Real-World Data, Rare Disease, and the Evolving Needs of Field Training
Real-world data (RWD) are playing an increasingly important role in understanding how therapeutics...
Regulatory Acceleration Is No Longer Hypothetical—It’s Here
The FDA has shifted from talking about acceleration to re-engineering how and when it intervenes in...
The FDA Is Signaling a Major Shift in How We Think About Evidence and Approval
In a recentNew England Journal of Medicinearticle, FDA officials Vinay Prasad and Martin Makary...
Applying the Power of Storytelling to Sales Conversations
”The purpose of a storyteller is not to tell you how to think, but to give you questions to think...
CLD Named Most Impactful Vendor 2018 by TGaS Advisors
“The awards are based on benchmarks conducted for life sciences companies in the biopharmaceutical...